Pathophysiological role of Atg5 in human ulcerative colitis

Area of Science:

• Gastroenterology
• Molecular Biology
• Immunology

Background:

• Ulcerative colitis (UC) is a major type of inflammatory bowel disease (IBD).
• Dysregulated autophagy is implicated in chronic diseases, including IBD.
• Atg5 and microRNA-181a (miR-181a) roles in UC pathophysiology require investigation.

Purpose of the Study:

• To investigate the role of Atg5 and miR-181a in the pathophysiology of ulcerative colitis (UC).
• To assess Atg5 levels in stool, serum, and intestinal tissue of UC patients and healthy controls.
• To evaluate miR-181a expression in blood samples from UC patients and healthy controls.

Main Methods:

• Collected colon biopsy, stool, and blood samples from UC patients and healthy controls (HCs).
• Measured Atg5 content using Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry.
• Quantified miR-181a expression via RNA extraction and evaluation from blood cells.

Main Results:

• Significantly higher Atg5 levels were found in the stool of UC patients (1.2 ng/mL) compared to HCs (0.46 ng/mL).
• No significant difference in miR-181a expression was observed between UC patients and HCs in blood samples.
• Immunohistochemistry revealed high Atg5 positivity in colon biopsies, with no significant quantitative difference between groups.

Conclusions:

• Elevated stool Atg5 levels in UC patients may serve as a potential diagnostic biomarker.
• Further research is warranted due to the small study population size.
• The role of miR-181a in UC pathophysiology requires additional investigation.